HIV antibodies among intravenous drug users in Bahrain.
A 12-month study was conducted to identify risk factors for human immunodeficiency virus (HIV) infections among intravenous drug users (IDU) attending drug rehabilitation clinic of the Psychiatric Hospital, Manama, Bahrain. Patients provided demographic and behavioural information based on a questionnaire. Two hundred and forty male IDUs participated in the study on voluntary basis. The seroprevalence of HIV was 21.1 per cent. The presence of HIV antibody was associated with educational status, frequency of injecting drugs and needle sharing.
al-Haddad
M K
MK
Psychiatric Hospital, Bahrain, Arabian Gulf.
Khashaba
A S
AS
Baig
B Z
BZ
Khalfan
S
S
D000328:Adult; D001445:Bahrain / Q000453:epidemiology; D006679:HIV Seropositivity / Q000150:complications*; D015528:HIV Seroprevalence; D015497:HIV-1 / Q000276:immunology*; D015498:HIV-2 / Q000276:immunology*; D006801:Humans; D008297:Male; D012959:Socioeconomic Factors; D015819:Substance Abuse, Intravenous / Q000150:complications*